1. Home
  2. INDV

INDV

Indivior PLC

Logo Indivior PLC

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 12:28pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.

Founded: 1994 Country:
United Kingdom
United Kingdom
Employees: N/A City: N/A
Market Cap: 2.7B IPO Year: N/A
Target Price: $37.00 AVG Volume (30 days): 1.2K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.01 EPS Growth: N/A
52 Week Low/High: N/A Next Earning Date: 04-25-2024
Revenue: $1,093,000,000 Revenue Growth: 21.31%
Revenue Growth (this year): 18.21% Revenue Growth (next year): 9.21%

Share on Social Networks: